A significantly higher frequency of Th1, Th17, Th22 and CD4+IFN-γ−IL-17A+IL-22+ T cells and significantly higher levels of serum IFN-γ, IL-17A and IL-22 existed in newly-diagnosed HT patients, related to that in the HC. The gene discussed is IL22; the disease is hematocrit.